These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Tilting the balance between RNA interference and replication eradicates Leishmania RNA virus 1 and mitigates the inflammatory response. Brettmann EA; Shaik JS; Zangger H; Lye LF; Kuhlmann FM; Akopyants NS; Oschwald DM; Owens KL; Hickerson SM; Ronet C; Fasel N; Beverley SM Proc Natl Acad Sci U S A; 2016 Oct; 113(43):11998-12005. PubMed ID: 27790981 [TBL] [Abstract][Full Text] [Related]
10. MyD88 and TLR9 dependent immune responses mediate resistance to Leishmania guyanensis infections, irrespective of Leishmania RNA virus burden. Ives A; Masina S; Castiglioni P; Prével F; Revaz-Breton M; Hartley MA; Launois P; Fasel N; Ronet C PLoS One; 2014; 9(5):e96766. PubMed ID: 24801628 [TBL] [Abstract][Full Text] [Related]
11. Type I interferons induced by endogenous or exogenous viral infections promote metastasis and relapse of leishmaniasis. Rossi M; Castiglioni P; Hartley MA; Eren RO; Prével F; Desponds C; Utzschneider DT; Zehn D; Cusi MG; Kuhlmann FM; Beverley SM; Ronet C; Fasel N Proc Natl Acad Sci U S A; 2017 May; 114(19):4987-4992. PubMed ID: 28439019 [TBL] [Abstract][Full Text] [Related]
12. Mammalian Innate Immune Response to a Leishmania-Resident RNA Virus Increases Macrophage Survival to Promote Parasite Persistence. Eren RO; Reverte M; Rossi M; Hartley MA; Castiglioni P; Prevel F; Martin R; Desponds C; Lye LF; Drexler SK; Reith W; Beverley SM; Ronet C; Fasel N Cell Host Microbe; 2016 Sep; 20(3):318-328. PubMed ID: 27593513 [TBL] [Abstract][Full Text] [Related]
14. Insights on Host-Parasite Immunomodulation Mediated by Extracellular Vesicles of Cutaneous Weber JI; Rodrigues AV; Valério-Bolas A; Nunes T; Carvalheiro M; Antunes W; Alexandre-Pires G; da Fonseca IP; Santos-Gomes G Cells; 2023 Apr; 12(8):. PubMed ID: 37190011 [TBL] [Abstract][Full Text] [Related]
15. Leishmania Viannia guyanensis, LRV1 virus and extracellular vesicles: a dangerous trio influencing the faith of immune response during muco-cutaneous leishmaniasis. Olivier M; Zamboni DS Curr Opin Immunol; 2020 Oct; 66():108-113. PubMed ID: 32877837 [TBL] [Abstract][Full Text] [Related]
16. Local Delivery of the Toll-Like Receptor 9 Ligand CpG Downregulates Host Immune and Inflammatory Responses, Ameliorating Established Leishmania (Viannia) panamensis Chronic Infection. Ehrlich AK; Fernández OL; Rodriguez-Pinto D; Castilho TM; Corral Caridad MJ; Goldsmith-Pestana K; Saravia NG; McMahon-Pratt D Infect Immun; 2017 Mar; 85(3):. PubMed ID: 28052994 [TBL] [Abstract][Full Text] [Related]
17. Nature of resistance to leishmaniasis in experimental rodents. Gorczynski RM Dev Comp Immunol; 1982; 6(2):199-207. PubMed ID: 6807726 [No Abstract] [Full Text] [Related]
18. da Silva Vieira T; Arango Duque G; Ory K; Gontijo CM; Soares RP; Descoteaux A Front Cell Infect Microbiol; 2019; 9():319. PubMed ID: 31555609 [No Abstract] [Full Text] [Related]
19. Further Evidence of an Association between the Presence of Leishmania RNA Virus 1 and the Mucosal Manifestations in Tegumentary Leishmaniasis Patients. Cantanhêde LM; da Silva Júnior CF; Ito MM; Felipin KP; Nicolete R; Salcedo JM; Porrozzi R; Cupolillo E; Ferreira Rde G PLoS Negl Trop Dis; 2015; 9(9):e0004079. PubMed ID: 26372217 [TBL] [Abstract][Full Text] [Related]
20. Surveillance of cutaneous leishmaniasis in clinical samples: distribution of Leishmania guyanensis in the state of Amapá, Brazil, 2018. Almeida ANF; Nascimento LCSD; Sousa ESMM; Oliveira AJD; Sena MG; Resende BM; Chaves RCG; Garcez LM Epidemiol Serv Saude; 2020; 29(1):e2018504. PubMed ID: 32074196 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]